a Geometric mean fold (GMF) rise from baseline to 14 days after dose 2 b Number of participants with ≥ 4 fold rise in titers from baseline to 14 days after dose 2 c p values comparing GMF-rise from ba
The purpose of this observer blinded study is to provide information on vaccine immunogenicity and reactogenicity in comparison with the US standard of care (ProQuad®) when administered with Hepatitis
Assess immuno, reacto of the 10-valent pneumococcal vaccine after 2 doses (2, 4 months of age) and after the complete 2, 4, 11 months schedule when co-administered with DTPa-HBV-IPV/Hib or DTPa-IPV/Hi